Joe Tambasco

Joe Tambasco

Associate

Email

Joe.Tambasco@aoshearman.com

Phone

+1 212 848 8192

Offices

New York

V-CARD
Joe represents financial institutions and public companies in connection with debt and equity offerings.
He also advises companies on their public disclosures, SEC and NYSE/Nasdaq compliance matters, and corporate governance matters.

Experience

Representative matters

  • The underwriters in connection with Kestra Medical Technologies Ltd.’s upsized $158.7 million follow-on equity offering.
  • Genmab A/S on its $1.5 billion senior secured notes offering and $1 billion senior unsecured notes offering to finance its acquisition of Merus N.V.
  • A global chemical company on its waterfall tender offer to purchase certain Euro-denominated and USD - denominated bonds for $1 billion.
  • The underwriters in connection with CSX Corporation’s $300 million bond offering.
  • A global chemical company on its $1.4 billion notes offering.
  • A biomedical and biotechnology company’s €1.5 billion bond offering.
  • A global chemical company in connection with its InterNotes® and Medium-Term Note programs.

Qualifications

Admissions

Attorney-at-law, State of New York, US, 2025

Academic

LLB (First Class), University College London, 2024

JD, Columbia Law School, 2024

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.